Interferon versus steroids in patients with hepatitis C virus-associated cryoglobulinaemic glomerulonephritis

Digestive and Liver Disease

Volumn 32, Issue 8, 2000, Pages 708-715

  Mazzaro, C ^a   Panarello, G ^b   Carniello, S ^c   Faelli, A ^c   Mazzi, G ^c   Crovatto, M ^c   Baracetti, S ^d   Nascimben, F ^d   Zorat, F ^d   Pozzato, G ^e   Faccini, L ^e   Campanacci, L ^e  

^a Third Department of Medicine   (Italy)

^b Department of Nephrology ^*  (Italy)

^c Laboratory of Immunology/Virology   (Italy)

^d UNIVERSITY OF TRIESTE   (Italy)

^e Blood Bank Serv of Pordenone G H   (Italy)

Author keywords

Alpha interferon; Chronic liver disease; Hepatitis C virus; Membrano proliferative glomerulonephritis; Mixed cryoglobulinaemia; Non Hodgkin's lymphoma

Indexed keywords

ALPHAN1 INTERFERON; CORTICOSTEROID; CYCLOPHOSPHAMIDE; LYMPHOBLAST INTERFERON; METHYLPREDNISOLONE; PREDNISONE; VIRUS RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GENOTYPE; GLOMERULONEPHRITIS; HEPATITIS C VIRUS; HUMAN; KIDNEY FAILURE; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEROID THERAPY; TREATMENT OUTCOME; VIRUS TYPING;

AGED; ANTI-INFLAMMATORY AGENTS; ANTIVIRAL AGENTS; CRYOGLOBULINEMIA; FEMALE; GENOTYPE; GLOMERULONEPHRITIS; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNOPHENOTYPING; INTERFERON-ALPHA; MALE; MIDDLE AGED; PREDNISONE; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 0033658159     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(00)80335-7     Document Type: Article

References (43)

1. Cryoglobulins
2. Cryoglobulinaemia and hepatic infection
3. A role for hepatitis C virus infection in type II cryoglobulinemia
4. Association between hepatitis C virus and mixed cryoglobulinemia
5. Hepatitis C virus in patients with cryoglobulinemia type II
6. Infection of peripheral mononuclear blood cells by hepatitis C virus
7. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia
8. Long-term follow-up study in essential mixed cryoglobulinemia
9. Low-grade malignant lymphoma, hepatitis C virus infection and mixed cryoglobulinemia
10. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection
11. Cryoglobulinemic membrano-proliferative glomerulonephritis associated with hepatitis C virus
12. Diffuse proliferative glomerulonephritis with hepatitis C virus-like particles in paramesangial dense deposits in a patient with chronic hepatitis C virus hepatitis
13. Renal disease in 18 patients with mixed type II IgM cryoglobulinemia: Monoclonal lymphoid infiltration (2 cases) and membrano-proliferative glomerulonephritis (14 cases)
14. Hepatitis C virus in renal tissue of patients with glomerulonephritis
15. Renal involvement in essential mixed cryoglobulinemia
16. Long term predictor of survival in essential mixed cryoglobulinemic glomerulonephritis
17. Long-term effects of alpha-interferon therapy for type II mixed cryoglobulinemia
18. Effects of two different alpha-interferon regimens on clinical and virological findings in mixed cryoglobulinemia
19. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus
20. Interferon in mixed cryoglobulinemia: A randomized cross-over controlled trial
21. Response to interferon treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus
22. Characterization of cryoglobulins by immunoblotting
23. Summary and description of a working formulation for clinical usage: The non-Hodgkin's lymphoma pathological classification project
24. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
25. Proof without prejudice: Use of the Kolmogorov-Smirnov test for the analysis of histograms from flow system and other sources
26. Detection of small numbers of monoclonal B lymphocytes in the blood of patients with lymphoma
27. The 5' terminal sequence of hepatitis C virus genome
28. Sequence analysis of the 5' non-coding region of hepatitis C virus
29. Molecular biology of the hepatitis C viruses. Implications for diagnosis, development and control of viral disease
30. Detection of serum hepatitis C virus RNA
31. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources
32. Characterization of the genomic sequence of the type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection
33. Molecular and clinical characteristics of the hepatitis C virus genotype ″2c″ found in Italians in Italy and France
34. A general method of in vitro preparation and specific mutagenesis of DNA fragments: Study of protein and DNA interaction
35. Site-directed mutagenesis by overlap extension using the polymerase chain reaction
36. Quantitative analysis of hepatitis C virus RNA in liver biopsies by competitive reverse transcription and polymerase chain reaction
37. Interferon-α in the treatment of membranoproliferative glomerulonephritis associated with hepatitis C virus infection: Do we have enough data or are we still in the learning stage?
38. Polymerase chain reaction for the detection of HCV-RNA: Cryoglobulinemia as a cause of false negative results
39. High prevalence of hepatitis C virus RNA in the supernatant and in the cryoprecipitate of patients with essential and secondary type II mixed cryoglobulinemia
40. Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia: Clinical and molecular findings do not support a bone marrow pathologic diagnosis of indolent B cell lymphoma
41. Randomised trial of interferon α2b plus ribavirin for 48 weeks or 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
42. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
43. Sustained response to interferon or to interferon plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinemia